Yunnan Botanee Bio-Technology Group Co.LTD is a Chinese health industry company primarily engaged in the research, development, production, and sales of skincare and cosmetic products as well as specialized medical devices. The company's core product lines include facial creams, lotions, masks, essences, sunscreens, powders, BB creams, makeup removers, and other skin care and cosmetic categories. It also develops medical devices featuring hyaluronic acid-based biofilms and dressings designed for the protection and care of skin barriers damaged by minimally invasive surgical procedures. The company markets its products under several brand names including Winona, Winona Baby, AOXMED, Beforteen, Za, and PURE&MILD, distributing through both offline and online channels. Additionally, Botanee produces household electronic radio frequency beauty equipment.
Founded in 2010 and headquartered in Kunming, China, Yunnan Botanee Bio-Technology Group has established itself as a "Skin Health Internet+" big health industry group, driving innovation by leveraging advanced technologies in dermatology, biology, and botany with a focus on active ingredients derived from unique Yunnan plateau plants. The company successfully listed on the Shenzhen Stock Exchange's Growth Enterprise Market in March 2021.
Significant recent developments include the official operation commencement of its new central factory base, which enhances the company’s independent production capacity and consolidates its foundational development. Botanee has actively expanded its research and industrial design capabilities, earning national recognition such as the National Industrial Design Center designation and the National Technological Innovation Demonstration Enterprise title. In early 2024, the company received accolades including the "Best Listed Company 2024" and "Best Practice in Investor Relations Management for Listed Companies," alongside an AAA ESG industry rating, underscoring a commitment to sustainability and corporate governance. The company has also seen recent ownership adjustments including a 2.5% stake acquisition by a group of buyers from Tianjin Sequoia Juye Equity. Botanee continues to innovate within the skin health ecosystem and expand its product offerings and market reach across China.
The company operates through various subsidiaries and joint ventures focused on specialty plant extraction, health technology, and medical biotechnology sectors, reinforcing its integrated approach to health and beauty products formation and distribution. This positions Yunnan Botanee Bio-Technology Group as a comprehensive player in China's skin health and cosmetic industries with an emphasis on medical-grade product innovations and scalable manufacturing infrastructure.